ProShares UltraShort Nasdaq Biotechnology
ProShare Advisors LLC BIS ETF
| BIS Price | $12.3476 |
Market Cap | $2.05M |
| Annual Dividend Yield | 6.32% |
Annual Dividend | $0.79 |
| Yearly Management Fee | 0.95% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $2.63K |
| Portfolio Management Company | ProShare Advisors LLC |
Discount/Premium to NAV | 0.11% |
| Inception Date | Apr 07, 2010 |
Market Cap Rank | 5129 |
| Monthly AUM Growth | -6.26% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Inverse 2x |
ProShares UltraShort Nasdaq Biotechnology is an ETF issued by ProShare Advisors LLC on Apr 07 2010.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of BIS ETF according to its net asset value is premiumed at 0.11%.
While the total value of the fund shows $-137,150 decrease compared to the previous month, its price is traded daily at a decrease of -0.85%.
The annual dividend yield of BIS ETF is 6.32%, whereas its main asset area is North America.
BIS ETF, whose 24-hour total volume is $2.63K, has experienced a $0 cash outflow in the last month.
In addition, ProShares UltraShort Nasdaq Biotechnology's net asset value total return is 0.00%.
BIS ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -0.85% |
-7.65% |
-9.67% |
-25.44% |
-28.88% |
-35.29% |
-60.50% |
BIS ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -1.09% |
-24.55% |
-33.22% |
-59.06% |
-66.43% |
-58.02% |
BIS ETF Comments
no comments yet